Literature DB >> 18812185

Human XPF controls TRF2 and telomere length maintenance through distinctive mechanisms.

Yili Wu1, Taylor R H Mitchell, Xu-Dong Zhu.   

Abstract

XPF-ERCC1, a structure-specific endonuclease, is involved in nucleotide excision repair, crosslink repair and homologous recombination. XPF-ERCC1 is also found to interact with TRF2, a duplex telomeric DNA binding protein. We have previously shown that XPF-ERCC1 is required for TRF2-promoted telomere shortening. However, whether XPF-ERCC1 by itself has a role in telomere length maintenance has not been determined. Here we report that overexpression of XPF induces telomere shortening in XPF-proficient cells whereas XPF complementation suppresses telomere lengthening in XPF-deficient cells. These results suggest that XPF-ERCC1 can function as a negative mediator of telomere length maintenance. In addition, we find that introduction of wild type XPF into XPF-deficient cells leads to over 40% reduction in TRF2 association with telomeric DNA, indicating that XPF-ERCC1 negatively regulates TRF2 binding to telomeric DNA. Furthermore, we show that XPF carrying mutations in the conserved nuclease domain fails to control TRF2 association with telomeric DNA but it is competent for modulating telomere length maintenance. These results imply that XPF-ERCC1 controls TRF2 and telomere length maintenance through two distinctive mechanisms, with the former requiring its nuclease activity. Our results further imply that TRF2 association with telomeres may be deregulated in cells derived from XPF patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812185     DOI: 10.1016/j.mad.2008.08.004

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  28 in total

Review 1.  Shelterin complex and associated factors at human telomeres.

Authors:  Raffaella Diotti; Diego Loayza
Journal:  Nucleus       Date:  2011 Mar-Apr       Impact factor: 4.197

2.  Cockayne syndrome group B protein regulates DNA double-strand break repair and checkpoint activation.

Authors:  Nicole L Batenburg; Elizabeth L Thompson; Eric A Hendrickson; Xu-Dong Zhu
Journal:  EMBO J       Date:  2015-03-27       Impact factor: 11.598

Review 3.  Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.

Authors:  Siobhán Q Gregg; Andria Rasile Robinson; Laura J Niedernhofer
Journal:  DNA Repair (Amst)       Date:  2011-05-25

4.  Effects of varying gene targeting parameters on processing of recombination intermediates by ERCC1-XPF.

Authors:  Jennifer J Rahn; Brian Rowley; Megan P Lowery; Luis Della Coletta; Tiffany Limanni; Rodney S Nairn; Gerald M Adair
Journal:  DNA Repair (Amst)       Date:  2010-11-30

Review 5.  The ERCC1 and ERCC4 (XPF) genes and gene products.

Authors:  Mandira Manandhar; Karen S Boulware; Richard D Wood
Journal:  Gene       Date:  2015-06-12       Impact factor: 3.688

6.  Role of Telomeric TRF2 in Orosphere Formation and CSC Phenotype Maintenance Through Efficient DNA Repair Pathway and its Correlation with Recurrence in OSCC.

Authors:  Arka Saha; Souvick Roy; Madhabananda Kar; Shomereeta Roy; Shweta Thakur; SwatiShree Padhi; Yusuf Akhter; Birendranath Banerjee
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

7.  The Cerebro-oculo-facio-skeletal Syndrome Point Mutation F231L in the ERCC1 DNA Repair Protein Causes Dissociation of the ERCC1-XPF Complex.

Authors:  Maryam Faridounnia; Hans Wienk; Lidija Kovačič; Gert E Folkers; Nicolaas G J Jaspers; Robert Kaptein; Jan H J Hoeijmakers; Rolf Boelens
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

8.  Arginine methylation regulates telomere length and stability.

Authors:  Taylor R H Mitchell; Kimberly Glenfield; Kajaparan Jeyanthan; Xu-Dong Zhu
Journal:  Mol Cell Biol       Date:  2009-07-13       Impact factor: 4.272

9.  The basic N-terminal domain of TRF2 limits recombination endonuclease action at human telomeres.

Authors:  Adélaïde Saint-Léger; Melanie Koelblen; Livia Civitelli; Amadou Bah; Nadir Djerbi; Marie-Josèphe Giraud-Panis; Arturo Londoño-Vallejo; Fiorentina Ascenzioni; Eric Gilson
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Therapeutic doses of hydroxyurea cause telomere dysfunction and reduce TRF2 binding to telomeres.

Authors:  Andrew R Snyder; Jing Zhou; Zhong Deng; Paul M Lieberman
Journal:  Cancer Biol Ther       Date:  2009-06-16       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.